NANOBCI
LIVE

Serial Number

50063057

Owner

Subsense, Inc.

Attorney

SHAILENDRA K MAHESHWARI

Filing Date

Aug 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NANOBCI Trademark

Serial Number: 50063057

NANOBCI is a trademark filed by Subsense, Inc. on August 20, 2026. The trademark is classified under Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Subsense, Inc. (9 trademarks)

440 North Barranca Ave 9106
Covina, CA 91723

Entity Type: 03

Trademark Details

Filing Date

August 20, 2026

Registration Date

Not Registered

Goods & Services

Software as a service (SaaS) services, including design and development, featuring non-downloadable software for use with brain-computer interface (BCI) devices and systems, enabling non-invasive neural activity stimulation and recording, signal capture and transmission, thought-controlled digital device interaction, enhanced human-machine integration, real-time brain activity monitoring, cognitive function enhancement, cognitive rehabilitation therapies, and improved accessibility for individuals with physical limitations; Research and development services in the field of brain-computer interfaces and biocompatible nanoparticle technology for enhancing human cognition and interaction with technology; Providing technology-based services and consultation, namely, development of technologies utilizing brain-computer interface (BCI) systems for real-time neural activity monitoring, aiding in the early detection and diagnosis of neurological conditions

Biocompatible plasmonic and magnetoelectric nanoparticles for use in brain-computer interface (BCI) systems, for integration with human brain tissue to enable non-invasive stimulation and recording of neural activity, and for real-time diagnostics for enhanced neurological treatments.

Medical devices featuring non-surgical, biocompatible nanoparticles for the treatment of neurological and neurodegenerative diseases through targeted brain stimulation; Brain-computer interface devices for medical use, designed to restore motor functions and enhance cognitive rehabilitation therapies; Health monitoring devices utilizing brain-computer interface (BCI) technology for real-time brain activity analysis and diagnostics, aiding in the treatment and understanding of neurological disorders; Medical devices for providing neurofeedback and biofeedback, supporting therapeutic interventions and cognitive enhancement.

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 20, 2026 MAFR
NEW APPLICATION ENTERED
Aug 20, 2026 NWAP